| Genetically distinct subsets within ANCA-associated vasculitis PA Lyons, TF Rayner, S Trivedi, JU Holle, RA Watts, DRW Jayne, ... New England Journal of Medicine 367 (3), 214-223, 2012 | 1074 | 2012 |
| Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER … D Roth, DR Nelson, A Bruchfeld, AM Liapakis, M Silva, H Monsour, ... The Lancet 386 (10003), 1537-1545, 2015 | 798 | 2015 |
| Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis DRW Jayne, AN Bruchfeld, L Harper, M Schaier, MC Venning, P Hamilton, ... Journal of the American Society of Nephrology 28 (9), 2756-2767, 2017 | 585 | 2017 |
| Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up L Harper, MD Morgan, M Walsh, P Hoglund, K Westman, O Flossmann, ... Annals of the rheumatic diseases 71 (6), 955-960, 2012 | 510 | 2012 |
| Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia RS Goldstein, M Gallowitsch-Puerta, LH Yang, M Rosas-Ballina, ... Shock 25 (6), 571-574, 2006 | 316 | 2006 |
| High‐dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C K Lindahl, L Stahle, A Bruchfeld, R Schvarcz Hepatology 41 (2), 275-279, 2005 | 268 | 2005 |
| Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis M Walsh, F Catapano, W Szpirt, K Thorlund, A Bruchfeld, L Guillevin, ... American Journal of Kidney Diseases 57 (4), 566-574, 2011 | 239 | 2011 |
| Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis RS Goldstein, A Bruchfeld, L Yang, AR Qureshi, M Gallowitsch-Puerta, ... Molecular medicine 13, 210-215, 2007 | 237 | 2007 |
| Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial RB Jones, TF Hiemstra, J Ballarin, DE Blockmans, P Brogan, A Bruchfeld, ... Annals of the rheumatic diseases 78 (3), 399-405, 2019 | 218 | 2019 |
| Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection–a pilot study A Bruchfeld, L Ståhle, J Andersson, R Schvarcz Journal of Viral Hepatitis 8 (4), 287-292, 2001 | 185 | 2001 |
| Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency A Bruchfeld, K Lindahl, L Ståhle, M Söderberg, R Schvarcz Nephrology Dialysis Transplantation 18 (8), 1573-1580, 2003 | 184 | 2003 |
| Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients A Bruchfeld, K Lindahl, O Reichard, T Carlsson, R Schvarcz Journal of viral hepatitis 13 (5), 316-321, 2006 | 178 | 2006 |
| Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis A Bruchfeld, K Lindahl, R Schvarcz, L Ståhle Therapeutic drug monitoring 24 (6), 701-708, 2002 | 170 | 2002 |
| Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation A Bruchfeld, H Wilczek, CG Elinder Transplantation 78 (5), 745-750, 2004 | 166 | 2004 |
| Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis RM Smith, RB Jones, U Specks, S Bond, M Nodale, R Aljayyousi, ... Annals of the rheumatic diseases 79 (9), 1243-1249, 2020 | 142 | 2020 |
| The COVID-19 pandemic: consequences for nephrology A Bruchfeld Nature Reviews Nephrology 17 (2), 81-82, 2021 | 137 | 2021 |
| Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis A Bruchfeld, RS Goldstein, S Chavan, NB Patel, M Rosas‐Ballina, N Kohn, ... Journal of internal medicine 268 (1), 94-101, 2010 | 129 | 2010 |
| High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD) A Bruchfeld, AR Qureshi, B Lindholm, P Barany, LH Yang, P Stenvinkel, ... Molecular medicine 14, 109-115, 2008 | 121 | 2008 |
| COVID-19 vaccines and kidney disease M Windpessl, A Bruchfeld, HJ Anders, H Kramer, M Waldman, L Renia, ... Nature Reviews Nephrology 17 (5), 291-293, 2021 | 119 | 2021 |
| Deoxyspergualin in relapsing and refractory Wegener’s granulomatosis O Flossmann, B Baslund, A Bruchfeld, JWC Tervaert, C Hall, P Heinzel, ... Annals of the rheumatic diseases 68 (7), 1125-1130, 2009 | 108 | 2009 |
